{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:05:17Z","timestamp":1789067117719,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.2146\/ajhp090313","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T17:46:35Z","timestamp":1274204795000},"page":"910-912","source":"Crossref","is-referenced-by-count":41,"title":["Withdrawal symptoms after gabapentin discontinuation"],"prefix":"10.1093","volume":"67","author":[{"given":"Thaddaus R.","family":"Hellwig","sequence":"first","affiliation":[{"name":"College of Pharmacy, South Dakota State University, Brookings\/Sioux Falls, and Clinical Pharmacist, Sanford Medical Center (SMC), Sioux Falls"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Hammerquist","sequence":"additional","affiliation":[{"name":"SMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Termaat","sequence":"additional","affiliation":[{"name":"Center for Family Medicine, Sioux Falls"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041104282616800_b1-0670910","first-page":"409","article-title":"Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy","volume":"43","author":"Goa","year":"1993","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041104282616800_b2-0670910","first-page":"353","article-title":"A Ca2+ channel \u03b12-\u03b4 ligand far beyond epilepsy therapy","volume":"44","author":"Striano","year":"2008","journal-title":"Drugs Today"},{"key":"key\n\t\t\t\t2019041104282616800_b3-0670910","first-page":"565","article-title":"Alpha2delta and the mechanism of action of gabapentin in the treatment of pain","volume":"17","author":"Maneuf","year":"2006","journal-title":"Semin Cell Dev Biol"},{"key":"key\n\t\t\t\t2019041104282616800_b4-0670910","first-page":"3628","article-title":"Pharmacological disruption of calcium channel trafficking by the \u03b12\u03b4 ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"key\n\t\t\t\t2019041104282616800_b5-0670910","first-page":"233","article-title":"A summary of mechanistic hypothesis of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res"},{"key":"key\n\t\t\t\t2019041104282616800_b6-0670910","first-page":"81","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t2019041104282616800_b7-0670910","first-page":"434","article-title":"A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder","volume":"67","author":"Vieta","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b8-0670910","first-page":"119","article-title":"Efficacy of gabapentin in migraine prophylaxis","volume":"41","author":"Mathew","year":"2001","journal-title":"Headache"},{"key":"key\n\t\t\t\t2019041104282616800_b9-0670910","first-page":"744","article-title":"Drug-resistant cluster headache responding to gabapentin: a pilot study","volume":"21","author":"Leandri","year":"2001","journal-title":"Cephalalgia"},{"key":"key\n\t\t\t\t2019041104282616800_b10-0670910","first-page":"1429","article-title":"A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia","volume":"32","author":"Brower","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"key\n\t\t\t\t2019041104282616800_b11-0670910","first-page":"1691","article-title":"Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Furieri","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b12-0670910","first-page":"107","article-title":"Treatment of alcohol withdrawal syndrome with gabapentin","volume":"32","author":"Bonnet","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b13-0670910","first-page":"129","article-title":"Gabapentin for the treatment of ethanol withdrawal","volume":"24","author":"Voris","year":"2003","journal-title":"Subst Abuse"},{"key":"key\n\t\t\t\t2019041104282616800_b14-0670910","first-page":"76","article-title":"A randomized, open-label controlled trial comparing gabapentin to phenobarbital in the treatment of alcohol withdrawal","volume":"15","author":"Mariani","year":"2006","journal-title":"Am J Addict"},{"key":"key\n\t\t\t\t2019041104282616800_b15-0670910","first-page":"514","article-title":"Treatment of acute alcohol withdrawal with gabapentin; results from a controlled two-center trial","volume":"23","author":"Bonnet","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019041104282616800_b16-0670910","first-page":"245","article-title":"Gabapentin withdrawal syndrome","volume":"24","author":"Norton","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"key\n\t\t\t\t2019041104282616800_b17-0670910","first-page":"483","article-title":"Gabapentin abuse, and delirium tremens upon gabapentin withdrawal","volume":"68","author":"Pittenger","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b18-0670910","first-page":"131","article-title":"Rebound psychiatric and physical symptoms after gabapentin discontinuation","volume":"59","author":"Cora-Locatelli","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b19-0670910","first-page":"302","article-title":"Gabapentin withdrawal syndrome in the presence of a taper","volume":"7","author":"Tran","year":"2005","journal-title":"Bipolar Disord"},{"key":"key\n\t\t\t\t2019041104282616800_b20-0670910","first-page":"925","article-title":"Gabapentin withdrawal presenting as status epilepticus","volume":"40","author":"Barrueto","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"key\n\t\t\t\t2019041104282616800_b21-0670910","first-page":"37","article-title":"Abuse, dependency and withdrawal with gabapentin: a first case report","volume":"40","author":"Victorri-Vigneau","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b22-0670910","first-page":"125","article-title":"Anorgasmia and withdrawal syndrome in a woman taking gabapentin","volume":"48","author":"Drabkin","year":"2003","journal-title":"Can J Psychiatry"},{"key":"key\n\t\t\t\t2019041104282616800_b23-0670910","first-page":"1353","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/11\/910\/28344249\/ajhp0910.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T21:20:54Z","timestamp":1555017654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/11\/910\/5130783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp090313","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,6,1]]},"published":{"date-parts":[[2010,6,1]]}}}